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Leucine has been suggested to have the potential to modulate muscle protein metabolism by increasing muscle protein synthesis. The objective of
this study was to investigate the surplus value of the co-ingestion of free leucine with protein hydrolysate and carbohydrate following physical
activity in elderly men. Eight elderly men (mean age 73 ^ 1 years) were randomly assigned to two cross-over treatments consuming either carbo-
hydrate and protein hydrolysate (CHO þ PRO) or carbohydrate, protein hydrolysate with additional leucine (CHO þ PRO þ leu) after performing
30 min of standardized physical activity. Primed, continuous infusions with L-[ring-13C6]phenylalanine and L-[ring-
2H2]tyrosine were applied, and
blood and muscle samples were collected to assess whole-body protein turnover as well as protein fractional synthetic rate in the vastus lateralis
muscle over a 6 h period. Whole-body protein breakdown and synthesis rates were not different between treatments. Phenylalanine oxidation rates
were significantly lower in the CHO þ PRO þ leu v. CHO þ PRO treatment. As a result, whole-body protein balance was significantly greater in
the CHO þ PRO þ leu compared to the CHO þ PRO treatment (23·8 (SEM 0·3) v. 23·2 (SEM 0·3) mmol/kg per h, respectively; P,0·05). Mixed
muscle fractional synthetic rate averaged 0·081 (SEM 0·003) and 0·082 (SEM 0·006) %/h in the CHO þ PRO þ leu and CHO þ PRO treatment,
respectively (NS). Co-ingestion of leucine with carbohydrate and protein following physical activity does not further elevate muscle protein frac-
tional synthetic rate in elderly men when ample protein is ingested.
Protein metabolism: Sarcopaenia: Muscle: Ageing
Ageing is associated with a gradual loss of skeletal muscle
mass, often referred to as sarcopaenia1. These age-related
changes in skeletal muscle mass are attributed to a disruption
in the regulation of skeletal muscle protein synthesis and/or
degradation2. Protein turnover in skeletal muscle tissue is
highly responsive to nutrient intake in healthy, young individ-
uals3. In the elderly, the muscle protein synthetic response to
food intake seems to be blunted4, which is likely due to
impaired anabolic signalling in skeletal muscle tissue5,6.
The latter has been proposed to represent a key factor in the
aetiology of sarcopaenia.
In addition to food intake, physical activity can effectively
modulate muscle protein metabolism, stimulating both muscle
protein synthesis and breakdown7. However, post-exercise net
protein balance will remain negative in the absence of food
intake8. Recently, we reported that co-ingestion of protein and
leucine with carbohydrate following physical activity can
increase muscle protein synthesis to the same extent in young
and elderly lean men9. The latter indicates that the combined
ingestion of carbohydrate and protein with additional free leu-
cine might indeed represent an effective strategy to further
increase muscle protein synthesis and/or to inhibit protein degra-
dation following physical activity10. A direct stimulating effect
of leucine administration on muscle protein synthesis has been
reported previously in rodents11 – 14. In line with those data,
Anthony et al.15 reported that leucine supplementation enhances
muscle protein synthesis in diabetic rats via activation of insulin-
independent mechanisms. Follow-up studies have shown that
leucine has the ability to function as a nutritional signalling mol-
ecule that stimulates muscle protein synthesis at the level of
translation initiation through the activation of mTOR16. In
addition, leucine has also been shown to have the potential to
*Corresponding author: Dr Rene´ Koopman, Department of Human Biology, Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands, fax þ31 43
3670976, email R.Koopman@HB.unimaas.nl
Abbreviations: AUC, area under the curve; EAA, essential amino acid; FSR, fractional synthetic rate; CHO þ PRO, carbohydrate and protein hydrolysate;
CHO þ PRO þ leu, carbohydrate, protein hydrolysate and additional free leucine.
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affect muscle protein metabolism by decreasing the rate of pro-
tein degradation17, most likely by stimulating insulin secretion.
In previous studies, we have shown that the combined ingestion
of carbohydrate, protein and leucine is more effective than the
ingestion of only carbohydrate in stimulating muscle protein
synthesis in vivo in man9,10. More recent data suggest that the
intake of amino acid mixtures or proteins with additional leucine
can further enhance muscle protein synthesis in the elderly18,19.
However, the proposed surplus value of leucine co-ingestion
under normal living conditions, in which physical activity is fol-
lowed by food intake, has not yet been assessed. We hypoth-
esized that additional co-ingestion of leucine together with
carbohydrate and protein improves whole-body protein balance
and further augments muscle protein synthesis rates following
physical activity in the elderly.
In the present study, we determined the potential surplus
value of free leucine co-ingestion on post-exercise muscle pro-
tein synthesis in elderly men (about 75 years old) under con-
ditions where large amounts of whey protein and carbohydrate
are being ingested. Continuous intravenous infusions with
L-[ring-13C6]phenylalanine and L-[ring-
2H2]tyrosine were
combined with plasma and skeletal muscle tissue sampling
to simultaneously measure whole-body protein balance as
well as muscle protein fractional synthetic rates in vivo in
elderly men.
Methods
Subjects
Eight healthy, lean elderly men (mean age 73 ^ 1 years), with
normal glucose tolerance and no history of participating in any
regular exercise training programme, were selected to partici-
pate in the present study. Subjects’ characteristics are shown
in Table 1. All subjects were informed about the nature and
risks of the experimental procedure before their written
informed consent to participate was obtained. The study was
approved by the local Medical Ethical Committee.
Pre-testing
Before selection in the study, all volunteers were subjected to
an oral glucose tolerance test20. Leg volume was determined
as described previously21, after which all subjects participated
in an orientation test to become familiarized with the physical
activity protocol and the equipment. Proper lifting technique
was demonstrated and practised for each of the two lower-
limb exercises (leg press and leg extension). Subsequently,
maximal strength (one-repetition maximum) was estimated
using the multiple repetitions testing procedure22.
Diet and activity prior to testing
All subjects consumed a standardized meal (64·1 (SEM 2·0)
kJ/kg body weight, consisting of (energy %): carbohydrate,
65, protein, 15 and fat, 20) the evening before the tests. All
volunteers were instructed to refrain from any sort of heavy
physical exercise and to keep their diet as constant as possible
3 d before the tests. In addition, subjects were asked to record
their food intake for 48 h before the start of the first test
and to consume the same diet 48 h before the start of the
second test.
Experimental tests
Each subject participated in two tests, separated by 7 d, in
which drinks containing carbohydrate and protein hydroly-
sate (CHO þ PRO) or carbohydrate, protein hydrolysate
and additional free leucine (CHO þ PRO þ leu) were admi-
nistered in a randomized and double-blind fashion. Each
test lasted approximately 8 h. Repeated boluses of a given
test-drink were ingested following the physical activity pro-
tocol to ensure a continuous supply of glucose and amino
acids. Plasma and muscle samples were collected during a
6 h period. These tests were designed to simultaneously
assess whole-body amino acid kinetics and fractional
synthetic rate (FSR) of mixed muscle protein by the incor-
poration of L-[ring-13C6]phenylalanine in the mixed protein
of muscle biopsies collected from the vastus lateralis
muscle.
Protocol
At 08.00 hours, after an overnight fast, subjects arrived at the
laboratory by car or public transportation to minimize the
effect of physical activity before the test on muscle FSR. A
Teflon catheter was inserted into an antecubital vein for
stable isotope infusion and a second Teflon catheter was
inserted in a heated dorsal hand vein of the contra-lateral
arm, placed in a hot-box (608C), for arterialized blood
sampling. After basal blood sample collection, a single intra-
venous dose of L-[ring-13C6]phenylalanine (2mmol/kg) and
L-[ring-2H2]tyrosine (0·775mmol/kg) was administered to
prime the phenylalanine and tyrosine pool. Thereafter, tracer
infusion (infusion rate of 0·049 (SEM 0·001) mmol/kg per
min for L-[ring-13C6]phenylalanine and 0·019 (SEM 0·001)
mol/kg per min for L-[ring-2H2]tyrosine) was started and sub-
jects rested in a supine position for 1 h, before engaging in the
standardized physical activity protocol. The protocol was
designed to simulate 30 min of moderate-intensity physical
activity (e.g. garden tasks such as lawn mowing) as has
been recommended by several public health authorities23,24.
The energy expenditure during such an activity pattern is esti-
mated to be approximately 650 kJ/30 min25, and was
simulated by combining low-intensity cycling and light resist-
Table 1. Characteristics of subjects (eight elderly men)
(Mean values with their standard errors)
Mean SEM
Age (years) 73 1
Weight (kg) 71·6 1·4
Height (m) 1·71 0·01
BMI (kg/m2) 24·5 0·7
Leg volume (litre) 7·80 0·20
Basal glucose (mmol/l) 5·34 0·13
Basal insulin (mU/l) 9·10 1·28
HOMA-IR 2·16 0·30
1RM leg press (kg) 154·9 6·6
1RM leg extension (kg) 77·5 2·5
HOMA-IR, homeostasis model assessment of insulin resistance34;
1RM, one-repetition maximum.
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ance-type exercise. After 5 min of self-paced cycling, subjects
performed six sets of ten repetitions on the horizontal leg press
machine (Technogym BV, Rotterdam, The Netherlands) and
six sets of ten repetitions on the leg extension machine (Tech-
nogym BV). The first two sets of both resistance exercises
were performed at 40 % of the subjects’ one-repetition maxi-
mum. Sets 3–4 and 5–6 were performed at 55 and 75 % of
one-repetition maximum, respectively, with 2 min rest
intervals between sets. At the end of the exercise protocol
(t 0 min), subjects rested supine and an arterialized blood
sample and a muscle biopsy from the vastus lateralis
muscle were collected. Subjects then received an initial
bolus (1·33 ml/kg) of a given test-drink. Repeated boluses
(1·33 ml/kg) were ingested every 30 min until t 330 min. Arter-
ialized blood samples were collected at t 15, 30, 45, 60, 75,
90, 120, 150, 180, 210, 240, 270, 300, 330 and 360 min
with a second muscle biopsy taken at t 360 min from the
contralateral limb.
Beverages
Subjects received a beverage volume of 1·33 ml/kg every
30 min to ensure a given dose of 0·49 g carbohydrate/kg
(50 % as glucose and 50 % as maltodextrin) and 0·16 g/kg of
a whey protein hydrolysate with or without the addition of
0·03 g/kg leucine every h. The total amount of protein
(0·16 g/kg per h or in total 0·96 g/kg) provided in the
CHO þ PRO and CHO þ PRO þ leu treatments exceeds the
calculated amount of protein needed to provide sufficient pre-
cursor substrate to sustain maximal protein synthesis rates for
at least 6 h26. Repeated boluses were administered to reach/
maintain steady-state conditions. The whey protein hydroly-
sate (68·8 % protein) contained 10·3 % leucine and conse-
quently the total amount of leucine administered in the
CHO þ PRO and CHO þ PRO þ leu treatments averaged
0·011 v. 0·041 g/kg per h, respectively.
Glucose and maltodextrin were obtained from AVEBE
(Veendam, The Netherlands). Whey protein hydrolysate was
prepared by DSM Food Specialties (Delft, The Netherlands).
Leucine was purchased from BUFA (Uitgeest, The Nether-
lands). To make the taste comparable in all treatments,
beverages were uniformly flavoured by adding 0·2 g sodium-
saccharinate solution (25 % w/w), 1·8 g citric acid solution
(50 % w/w) and 5 g of cream vanilla flavour (Numico
Research, Wageningen, The Netherlands) for each litre of
beverage. Treatments were performed in a randomized
order, with test-drinks provided in a double-blind fashion.
Analysis
Blood samples were collected in EDTA-containing tubes and
centrifuged at 1000 g and 48C for 5 min. Aliquots of plasma
were frozen in liquid nitrogen and stored at2808C. Plasma glu-
cose (Uni Kit III, 07367204; Roche, Basel, Switzerland) concen-
trations were analysed with the COBAS-FARA semi-automatic
analyser (Roche). Insulin was analysed by RIA (Insulin RIA Kit;
LINCO Research Inc., St Charles, MO, USA). Plasma (500ml)
for amino acid analyses was deproteinized on ice with 24 %
(w/v) 5-sulphosalicylic acid (100ml), mixed and the clear super-
natant was collected after centrifugation. Plasma amino acid
concentrations were analysed on an automated dedicated
amino acid analyser (LC-A10; Shimadzu Benelux, Den Bosch,
The Netherlands), using an automated precolumn derivatization
procedure and a ternary solvent system27. The exact phenyl-
alanine and tyrosine concentrations in the infusates were
measured using the same method and averaged 4·58 (SEM
0·01) and 1·79 (SEM 0·01) mmol/l, respectively. Plasma phenyl-
alanine and tyrosine were derivatized to their tert-butyldi-
methylsilyl derivatives and their 13C and/or 2H enrichments
were determined by electron ionization GC–MS (GC, Agilent
6890N; MSD, Agilent 5973N, Little Falls, DE, USA) using
selected ion monitoring of masses 336 and 342 for unlabelled
and labelled phenylalanine, respectively, and masses 466, 468
and 472 for unlabelled and labelled (ring-2H2 and ring-
13C6)
tyrosine, respectively28.
For measurement of L-[ring-13C6]phenylalanine enrichment
in the free amino acid pool and mixed muscle protein, 55 mg wet
muscle were freeze-dried. Collagen, blood and other non-
muscle fibre material were removed from the muscle fibers
under a light microscope. The isolated muscle fibre mass (2–
3 mg) was weighed and eight volumes (8 £ dry weight of iso-
lated muscle fibres £ wet/dry ratio) of ice-cold 2 % perchloric
acid were added. The tissue was then homogenized and centri-
fuged. The supernatant was collected and processed in the
same manner as the plasma samples, such that intracellular
free L-[ring-13C6]phenylalanine, L-[ring-
2H2]tyrosine and L-
[ring-13C6]tyrosine enrichments could be measured using their
t-butyldimethylsilyl derivatives on a GC–MS. The free amino
acid concentration in the supernatant was measured using an
HPLC technique, after precolumn derivatization with o-phthal-
dialdehyde29. The protein pellet was washed with three
additional 1·5 ml washes of 2 % perchloric acid, dried and the
proteins were hydrolysed in 6 M-HCl at 1208C for 15–18 h.
The hydrolysed protein fraction was dried under a nitrogen
stream while heated to 1208C, then dissolved in a 50 % acetic
acid solution, and passed over a Dowex exchange resin (AG
50W-X8, 100–200 mesh hydrogen form; BioRad, Hercules,
CA, USA) using 2 M-NH4OH. Thereafter, the eluate was dried
and the purified amino acid fraction was derivatized into
the ethoxycarbonyl-ethylesters to determine the 13C-enrichment
of protein-bound phenylalanine using GC–IRMS (MAT 252,
Finnigan, Bremen, Germany).
Calculations
Infusion of L-[ring-13C6]phenylalanine and L-[ring-
2H2]tyrosine
with muscle and arterialized blood sampling was used to simul-
taneously assess whole-body amino acid kinetics and FSR of
mixed muscle protein. We did not use the L-[1-13C]leucine
tracer to study protein metabolism as it has been shown that
amino acid oxidation during and following exercise is overesti-
mated with that particular tracer30. Whole-body kinetics for
phenylalanine and tyrosine were calculated using the equations
described by Thompson et al.31 and Short et al.32. Briefly,
phenylalanine and tyrosine turnover (flux, Q) was measured
from the isotope dilution at isotopic steady state:
Q ¼ i Ei
Ep
2 1
 
ð1Þ
where i is the isotope infusion rate (mmol/kg body weight per h)
and Ei and Ep correspond to the enrichments of infusate and
Anabolic properties of leucine co-ingestion 573
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plasma amino acids (mol % excess), respectively. At isotopic
steady state, protein flux (Q) equals the sum of protein synthesis
(S) and oxidation (O) as well as the sum of the rate of appearance
of meal protein from the gut (I) and protein breakdown (B);
whole-body protein synthesis rate was calculated as flux minus
oxidation.
Q ¼ Sþ O ¼ Bþ I ð2Þ
S ¼ Q2 O ð3Þ
At isotopic steady state, whole-body phenylalanine oxidation
can be determined from the conversion (hydroxylation) of
L-[ring-13C6]phenylalanine to L-[ring-
13C6]tyrosine. The rate
of hydroxylation (Qpt) was calculated (31) using the formula
Qpt ¼ Qt Et
Ep
 Qpðip þ QpÞ ð4Þ
whereQt andQp are the flux rates for tyrosine and phenylalanine,
respectively. Et and Ep are the L-[ring-
13C6]tyrosine and
L-[ring-13C6]phenylalanine enrichments in plasma, respectively
and ip is the infusion rate of the phenylalanine tracer.
Fractional rate of mixed muscle protein synthesis (FSR) was
calculated by dividing the increment in enrichment in the
product, i.e. protein-bound L-[ring-13C6]phenylalanine, by the
enrichment of the precursor (plasma L-[ring-13C6]phenylalanine
enrichment). Muscle FSR was calculated as follows10:
FSR ¼ DEp
Eprecursort 100 ð5Þ
whereDEp is the delta increment of protein bound L-[ring-
13C6]-
phenylalanine during incorporation periods; Eprecursor is the
average plasma L-[ring-13C6]phenylalanine enrichment to be
able to correct for potential changes in precursor enrichment
due to protein ingestion during the time period for determination
of amino acid incorporation; t indicates the time interval (h)
between biopsies and the factor 100 is needed to express the
FSR in percent per hour (%/h).
Statistics
All data are expressed as means and their standard errors. The
plasma essential amino acid (EAA), insulin and glucose
responses were calculated as area under the curve above base-
line values (AUC). A two-factor repeated measures ANOVA
with time and treatment as factors was used to compare differ-
ences between treatments over time. In case of significant
F ratios, Scheffe post-hoc tests were applied to locate the
differences. For non-time-dependent variables, paired Stu-
dent’s t tests were used to compare differences in treatment
effect. Statistical significance was set at P,0·05. All calcu-
lations were performed using StatView version 5.0 (SAS Insti-
tute Inc., Cary, NC, USA).
Results
Plasma insulin and glucose
In both treatments, plasma insulin concentrations increased
during the first 45 min following the ingestion of the first bev-
erage, after which insulin concentrations remained elevated
throughout the recovery period. No significant differences in
plasma insulin concentrations were observed over time
between treatments. The insulin response, expressed as AUC
above baseline values during the entire 6 h post-exercise
period (Fig. 1), was significantly greater in the CHO þ
PRO þ leu compared with the CHO þ PRO treatment (17·7
(SEM 1·5) v. 14·9 (SEM 1·9) U·6 h/l, respectively, P,0·05),
and represented a 28 (SEM 14) % difference between
treatments. Plasma glucose concentrations increased during
the first 30–60 min after ingestion of the first beverage in
both treatments, after which concentrations slowly decreased
over time. No differences in plasma glucose response were
observed between CHO þ PRO and CHO þ PRO þ leu
treatment (779 (SEM 48) v. 763 (SEM 63) mmol·6 h/l,
respectively, NS).
Plasma amino acids
Plasma leucine, phenylalanine and tyrosine concentrations over
time are reported in Fig. 2. The plasma phenylalanine and tyro-
sine responses (AUC above baseline values) did not differ
between treatments (2·86 (SEM 0·48) v. 2·08 (SEM 0·42)
mmol·6 h/l and 5·49 (SEM 1·18) v. 3·89 (SEM 1·18) mmol·6 h/l
in the CHO þ PRO and CHO þ PRO þ leu treatment, respect-
ively; NS). The plasma leucine response (AUC) was signifi-
cantly higher in the CHO þ PRO þ leu compared to the
CHO þ PRO treatment (131·04 (SEM 14·16) v. 51·11 (SEM
11·46) mmol·6 h/l, respectively, P,0·001). Plasma histidine,
lysine, phenylalanine, threonine and tryptophan responses
(Fig. 3(A)) did not differ between treatments. Plasma isoleu-
cine, methionine and valine responses (Fig. 3(A)) were signifi-
cantly lower in the CHO þ PRO þ leu compared to the
CHO þ PRO treatment (10·71 (SEM 1·25) v. 14·40 (SEM 1·29)
mmol·6 h/l, 1·02 (SEM 0·56) v. 1·85 (SEM 0·43) mmol·6 h/l and
Fig. 1. Plasma insulin responses (expressed as area under the curve minus
baseline values) in elderly men (n 8) while ingesting carbohydrate and pro-
tein (0·49 and 0·16 g/kg per h, respectively; CHO þ PRO) or carbohydrate
and protein with additional free leucine (0·49, 0·16 and 0·1 g/kg per h,
respectively; CHO þ PRO þ leu). Values are means with their standard
errors depicted by vertical bars. Mean values were significantly different from
those of the CHO þ PRO experiment: *P,0·05.
R. Koopman et al.574
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3·83 (SEM 3·23) v. 12·85 (SEM 2·10) mmol·6 h/l, respectively;
P,0·05). The plasma EAA response (with the exclusion of
leucine) was significantly lower in the CHO þ PRO þ leu
compared to the CHO þ PRO treatment (77·12 (SEM 12·37)
v. 98·08 (SEM 9·08) mmol·6 h/l, respectively; Fig. 3(B);
P,0·05).
The time course of the changes in plasma L-[ring-13C6]-
phenylalanine, L-[ring-2H2]tyrosine and L-[ring-
13C6]tyrosine
enrichments are shown in Fig. 4. No differences in plasma
L-[ring-13C6]phenylalanine, L-[ring-
2H2]tyrosine and L-
[ring-13C6]tyrosine enrichments were observed over time
between treatments.
Whole-body protein metabolism
Phenylalanine flux was similar in the CHO þ PRO and
CHO þ PRO þ leu treatment (49·5 (SEM 1·2) v. 48·8 (SEM
1·1) mmol phenylalanine/kg per h, respectively; NS). Tyro-
sine flux was significantly lower in the CHO þ PRO þ leu
compared to the CHO þ PRO treatment (49·5 (SEM 1·7) v.
52·3 (SEM 1·6) mmol tyr/kg per h, respectively; P,0·05).
Whole-body protein breakdown and synthesis (Fig. 5), cal-
culated over the 6 h post-exercise recovery, did not differ
between treatments. The rate of whole-body phenylalanine
oxidation (Fig. 5), calculated from the conversion of phenyl-
alanine to tyrosine, was lower in the CHO þ PRO þ leu
compared with the CHO þ PRO treatment (3·63 (SEM
0·31) v. 4·29 (SEM 0·33) mmol/kg per h, respectively;
P,0·05). Whole-body protein balance (Fig. 5) was signifi-
cantly greater in the CHO þ PRO þ leu compared with
the CHO þ PRO treatment (23·8 (SEM 0·3) v. 23·2 (SEM
0·3) mmol/kg per h, respectively; P,0·05). Protein synthesis
efficiency (whole-body protein synthesis as a percentage of
the phenylalanine flux) was significantly higher in the
CHO þ PRO þ leu compared with the CHO þ PRO treat-
ment (92·6 (SEM 0·6) v. 91·3 (SEM 0·6) %, respectively
P,0·05).
Muscle analysis
Mean plasma L-[ring-13C6]phenylalanine, L-[ring-
2H2]tyrosine
and L-[ring-13C6]tyrosine enrichments during the last 4 h of
recovery, muscle free L-[ring-13C6]phenylalanine, L-[ring-
2H2]-
tyrosine and L-[ring-13C6]tyrosine enrichments in the 6 h post-
exercise biopsy and the increments in muscle protein enrichment
are presented in Table 2. No differences in free L-[ring-13C6]-
phenylalanine, L-[ring-2H2]tyrosine and L-[ring-
13C6]tyrosine
enrichments in the muscle biopsies collected 6 h after physical
activity were observed between treatments. The increase in pro-
tein-bound L-[ring-13C6]phenylalanine enrichment during the
CHO þ PRO and CHO þ PRO þ leu treatments averaged
0·000341 (SEM 0·000030) and 0·000341 (SEM 0·000045)
(tracer/tracee ratio), respectively, with no significant differences
between treatments.
Fig. 2. Plasma leucine (A), phenylalanine (B) and tyrosine (C) concentrations
(mmol/l), in the carbohydrate and protein (CHO þ PRO, P) and carbohydrate
and protein with additional free leucine (CHO þ PRO þ leu, L) treatments in
elderly men (n 8). Values are means with their standard errors depicted
by vertical bars. Data were analysed with ANOVA repeated measures
(treatment £ time). Plasma leucine: treatment effect, P,0·05; time
effect, P,0·001; interaction of treatment and time, P,0·001. Plasma
phenylalanine: treatment effect, P¼0·33; time effect, P,0·001; interaction of
treatment and time, P¼0·291. Plasma tyrosine: treatment effect, P¼0·451;
time effect, P,0·001; interaction of treatment and time, P,0·01. Mean
values were significantly different from those of the CHO þ PRO experiment
(Scheffe’s test): *P,0·05).
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Mixed muscle protein synthesis rates
Mixed muscle protein FSR, with the mean plasma L-[ring-13C6]-
phenylalanine enrichment as precursor (Fig. 6), averaged 0·081
(SEM 0·003) and 0·082 (SEM 0·006) %/h in the CHO þ PRO þ
leu and CHO þ PRO treatment, respectively. No differences
were observed in FSR between treatments.
Discussion
In the present study, we determined the potential surplus value
of free leucine co-ingestion on post-exercise muscle protein
synthesis in elderly men (approximately 75 years old) under
conditions where large amounts of whey protein and carbo-
hydrate are being ingested. Therefore, we assessed whole-
body protein turnover and determined mixed muscle protein
synthesis rates following the ingestion of carbohydrate and
protein with or without additional free leucine in lean, elderly
men. Additional intake of free leucine was shown to reduce
whole-body protein oxidation, thereby improving whole-
body protein balance. Direct measurement of mixed muscle
protein synthesis rates revealed that co-ingestion of free leu-
cine does not further enhance muscle protein synthesis rates
following physical activity when ample amounts of protein
and carbohydrate are ingested.
The potential role of leucine as a regulator of muscle pro-
tein metabolism has been studied extensively33. Leucine was
reported to stimulate protein synthesis effectively in isolated
rat diaphragm muscle33. The latter has since been confirmed
in many follow-up studies in rodents11 – 14. Moreover, Anthony
et al.15 provided evidence showing that leucine ingestion can
stimulate muscle protein anabolism both by increasing insulin
secretion and by stimulating protein synthesis via insulin-inde-
pendent mechanisms. Such a stimulating effect of leucine on
protein synthesis occurs at the level of mRNA translation
initiation and involves signalling through mTOR34, which is
thought to serve as a convergence point for leucine- and
insulin-mediated effects on mRNA translation initiation.
These observations indicate that leucine has the ability to
function as a nutritional signalling molecule that can modulate
muscle protein synthesis.
As a result, there have been ample recent studies examining
the role of leucine in the control of tissue protein metabolism,
its mechanism of action, and its proposed applicability in
effective nutritional interventions to improve muscle protein
balance in the elderly and in cachectic patients. We have
recently shown that the combined ingestion of carbohydrate,
protein and leucine is more effective in stimulating
muscle protein synthesis in vivo in man when compared
with the ingestion of only carbohydrate9,10. In addition,
more recent studies reported that ingestion of a leucine-
enriched amino acid mixture18,19 or co-ingestion of leucine
with protein18,19 effectively enhance muscle protein synthesis
in the elderly. However, the surplus value of additional leucine
ingestion under normal living conditions, in which physical
activity is followed by ample food intake, has not been
assessed. Therefore, in the present study, we investigated the
effect of carbohydrate (0·49 g/kg per h) and protein (0·16 g/
kg per h) ingestion with or without additional free leucine
(0·03 g/kg per h) on muscle protein synthesis rates following
physical activity in lean, elderly men (approxiamtely 75
years old).
Though most in vitro and in vivo animal studies report that
leucine administration stimulates protein synthesis, most
in vivo human studies report that leucine and/or branched-
chain amino acid administration reduces muscle protein break-
down, without stimulating muscle protein synthesis35. In line
with these findings, we observed lower phenylalanine oxi-
dation rates in the CHO þ PRO þ leu treatment (expressed
both absolute as well as a percentage of total phenylalanine
flux) compared with the CHO þ PRO treatment (Fig. 5).
The latter implies that a greater proportion of the rate of dis-
appearance of phenylalanine is used for protein synthesis (i.e.
greater protein synthesis efficiency). As a consequence, net-
protein balance was greater in the CHO þ PRO þ leu v.
CHO þ PRO treatment. The latter could, in part, be attributed
Fig. 3. Plasma response of the individual essential amino acids (EAA; A) and total essential amino acid response with the exclusion of leucine (B) during the
carbohydrate and protein (CHO þ PRO, A) and carbohydrate and protein with additional free leucine (CHO þ PRO þ leu, ) treatments in elderly men (n 8).
Values are means with their standard errors depicted by vertical bars. Mean values were significantly different from those of the CHOþPRO experiment (paired
t test): *P,0·05. his, histidine; ile, isoleucine; leu, leucine; lys, lysine; met, methionine; phe, phenylalanine; thr, threonine; trp, tryptophan; val, valine.
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to the greater insulin response that was observed in the
CHO þ PRO þ leu v. CHO þ PRO treatment (Fig. 1). How-
ever, in the present study, we cannot differentiate between
the insulin-dependent and/or insulin-independent pathways
that might explain the improved protein balance following leu-
cine co-ingestion. Using whole-body tracer methodology, the
present study indicates that the co-ingestion of free leucine
with protein and carbohydrate further reduces whole-body
protein oxidation rates (Fig. 5). The latter is in line with earlier
reports by Nair et al.17, showing leucine infusion to reduce
Fig. 4. Plasma L-[ring-13C6]phenylalanine (A), L-[ring-
2H2]tyrosine (B) and
L-[ring-13C6]tyrosine enrichment (C) during the carbohydrate and protein
(CHO þ PRO, P) and carbohydrate and protein with additional free leucine
(CHO þ PRO þ leu, 7) treatments in elderly men (n 8). Values are means
with their standard errors depicted by vertical bars. Data were analysed with
ANOVA repeated measures (treatment £ time). Plasma L-[ring-13C6]-
phenylalanine enrichment: treatment effect, P¼0·75; time effect, P,0·001;
interaction of treatment and time, P¼0·40. Plasma L-[ring-2H2]tyrosine
enrichment: treatment effect, P¼0·52; time effect, P,0·001; interaction of
treatment and time, P¼0·42. Plasma L-[ring-13C6]tyrosine enrichment: treat-
ment effect, P¼0·39; time effect, P,0·001; interaction of treatment and time,
P¼0·51. TTR, tracer/tracee ratio.
Fig. 5. Whole-body protein breakdown, synthesis, and oxidation rates and
net protein balance (expressed as mmol phenylalanine/kg per h) during the
carbohydrate and protein (CHO þ PRO) and carbohydrate and protein with
additional free leucine (CHO þ PRO þ leu) experiments in elderly men (n 8).
Values are means with their standard errors depicted by vertical bars. Mean
values were significantly different from those of the CHO þ PRO experiment
(paired t test): *P,0·05.
Fig. 6. Fractional synthetic rate (FSR) of mixed muscle protein following the
ingestion of carbohydrate and protein (CHO þ PRO) or carbohydrate and
protein with additional free leucine (CHO þ PRO þ leu) in elderly men (n 8).
Values are means with their standard errors depicted by vertical bars. No sig-
nificant differences were observed between treatments (paired t test):
P.0·05.
Anabolic properties of leucine co-ingestion 577
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
whole-body protein breakdown significantly. Furthermore,
data from their study also showed a decline in the plasma con-
centrations of the other EAA during leucine infusion. In
accordance, we observed reduced plasma EAA responses
in the CHO þ PRO þ leu v. CHO þ PRO treatment, even
though the same amount of protein was consumed (Fig. 3).
The diminished plasma EAA response following leucine sup-
plementation could be attributed to a reduced release from
the muscle, and as such, could be indicative of a reduced pro-
tein breakdown and/or oxidation rate (Fig. 5). In addition, it
has been suggested that leucine influences the transport
of amino acids sharing the same transport system (i.e.
valine, isoleucine)36. Though we did not assess either valine
or isoleucine kinetics, it might be speculated that a reduction
in their plasma concentration following leucine co-ingestion
could prevent a further increase in muscle protein synthesis
rate.
In the present study, we infused L-[ring-13C6]phenylalanine
and measured L-[ring-13C6]phenylalanine and L-[ring-
13C6]-
tyrosine enrichment in plasma and free muscle amino acid
pool. Consequently, we observed 50–120 % higher tyrosine
enrichments in the free muscle amino acid pool compared to
values observed in plasma (Table 2)9,10. The latter might
suggest that phenylalanine is converted to tyrosine in skeletal
muscle, as was previously suggested by Van Hall et al.37.
However, these findings are in contrast with previous obser-
vations in rodents38. The latter should be investigated in
more detail in future studies.
The combined ingestion of leucine and protein with carbo-
hydrate has been shown to stimulate endogenous insulin
release (Fig. 1)10,39,40. In the present study, the greater insulin
response following leucine co-ingestion was not accompanied
by a reduction in plasma glucose concentration. The latter has
been reported before in healthy, normoglycaemic subjects39.
In contrast, the greater insulin response following protein
and/or leucine co-ingestion has been shown to stimulate
plasma glucose disposal, and attenuate the postprandial rise
in blood glucose under hyperglycaemic conditions in type 2
diabetes patients39. Leucine ingestion has been proposed to
stimulate muscle protein synthesis, independent of circulating
plasma insulin levels, by increasing the phosphorylation (acti-
vation) of key proteins involved in the regulation of protein
synthesis41. As a consequence, it has been speculated that
the administration of an insulinotropic mixture containing
carbohydrate, protein and additional free leucine likely rep-
resents an effective nutritional strategy to enhance net
muscle protein accretion in the elderly9,18,19. In addition to
whole-body measurements, we measured the incorporation
rate of labelled phenylalanine in skeletal muscle tissue to
determine the FSR of mixed muscle protein in the vastus
lateralis muscle. Mixed muscle FSR averaged 0·082 (SEM
0·006 %/h following 6 h after physical activity, during which
carbohydrate and protein (0·49 and 0·16 g/kg per h, respect-
ively) were ingested (Fig. 6). Additional intake of free leucine
(0·03 g/kg per h) did not further increase muscle protein
synthesis rates (Fig. 6), as muscle FSR averaged 0·081 (SEM
0·006) %/h in the CHO þ PRO þ leu treatment. Therefore,
the present data show that co-ingestion of free leucine
does not further enhance muscle protein synthesis in lean
elderly men.
The present data seem to be in contrast with recently pub-
lished studies18,19. Katsanos et al.19 showed that in elderly
men, ingestion of 6·7 g of an EAA mixture containing 41 % leu-
cine was more effective in stimulating muscle protein synthesis
rates when compared to an EAA mixture containing only 26 %
leucine. Similarly, Rieu et al.18 showed that co-ingestion of leu-
cine (and small amounts of valine and isoleucine) with protein,
carbohydrate and fat further improved muscle protein synthesis
in elderly men. The apparent discrepancy could likely be
explained by the fact that in the present study, FSR was
assessed following physical activity. Furthermore, our subjects
were administered a much greater protein/carbohydrate load
when compared to these other studies. The total amount of pro-
tein ingested in the present study averaged 69 (SEM 1) g v.
merely 30 and 6·7 g in the studies by Rieu et al.18 and Katsanos
et al.19. Furthermore, the total amount of leucine that was
ingested (4·7 and 17·6 g leucine over a 6 h period in the
CHO þ PRO and CHO þ PRO þ leu treatment, respectively)
was substantially greater than the lowest dose of leucine pro-
vided either by Katsanos et al.19 (1·7 g over a 3·5 h period) or
Rieu et al.18 (3 g over a 5 h period). Therefore, it could be
speculated that the leucine and/or exercise-stimulated protein
synthetic response had already reached maximal values in the
CHO þ PRO treatment.
Table 2. Plasma and muscle tracer kinetics
(Mean values with their standard errors)
Plasma amino acid
enrichment*
Muscle amino acid
pool enrichment*
D Enrichment muscle
protein*
Mean SEM Mean SEM Mean SEM
L-[ring-13C6]phenylalanine
CHO þ PRO 0·0743 0·0014 0·0567 0·0021 0·000371 0·000029
CHO þ PRO þ leu 0·0752 0·0010 0·0598 0·0031 0·000371 0·000017
L-[ring-2H2]tyrosine
CHO þ PRO 0·0329 0·0008 0·0210 0·0007 NA NA
CHO þ PRO þ leu 0·0339 0·0006 0·0217 0·0011 NA NA
L-[ring-13C6]tyrosine
CHO þ PRO 0·0060 0·0002 0·0099 0·0001 NA NA
CHO þ PRO þ leu 0·0054 0·0002 0·0111 0·0017 NA NA
CHO þ PRO, carbohydrate and protein hydrolysate; CHO þ PRO þ leu, carbohydrate, protein hydrolysate and
additional free leucine; NA, not applicable.
* Enrichment expressed as tracer/tracee ratio.
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Though leucine co-ingestion did not further stimulate
muscle protein synthesis, whole-body protein balance was
shown to be 2·8 % greater in the CHO þ PRO þ leu trial
(P,0·05; Fig. 5). The relevance of such small differences in
whole-body protein balance and the tissue(s) responsible for
these small differences could not be determined in the present
study. Long-term intervention studies are warranted to address
the efficacy of leucine supplementation as an interventional
strategy to attenuate the loss of skeletal muscle mass with
ageing.
In conclusion, co-ingestion of leucine with protein and
carbohydrate following physical activity does not further aug-
ment mixed muscle protein synthesis rates in lean, elderly men
under conditions where ample amounts of protein and carbo-
hydrate are being ingested.
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